Print
Email
Print Edition StoriesThursday, November 19, 2009
German biotech Caprotec opens Burlington subsidiary
By Mass High Tech staff
MHT's Julie Donnelly: Life science startups finding investments
MHT's Marc Songini: Technology to keep seniors healthy
MHT's Marc Songini: Mass. bio firms prep for lifting of stem cell ban
Caprotec bioanalytics GmbH, a Berlin biotechnology firm, has opened a subsidiary in Burlington. Called caprotec Inc., the subsidiary will cover North American sales, support and marketing for its Capture Compound Mass Spectrometry (CCMS) technology.
Caprotec’s CCMS technology, used in proteomics research, focuses on small molecules that capture and isolate proteins based on functionality.
The company announced, as part of the new subsidiary, Christian Jurinke, a biotech veteran most recently of San Diego-based Sequenom Inc., would take over as president of the U.S. subsidiary. Genovative Solutions LLC, a biotech research tools firm with which caprotec has partnered for sales and marketing, has brought in its founder Jeff Protentis as the Burlington subsidiary’s lead agent in North America.
Other biotech-focused spectrometry companies include Woburn-based biotech BioTrove Inc., which last week announced plans to be acquired by Carlsbad, Calif.-based Life Technologies Corp. and Waters Corp. of Milford, which announced in April plans to establish a center at the University of Warwick in England focused on biomedical mass spectrometry research.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
